نتایج جستجو برای: leucovorin

تعداد نتایج: 2615  

Journal: :Oncology 1999
E Richardet C Pedraza E Mickiewicz G Lerzo M Bonamasa F Coppola A Elli G Uranga S Jovtis M Bruno M Ventriglia M A Cuevas A M Alvarez L A Suarez L Fein

Uracil and tegafur (in a molar ratio of 4:1 [UFT]) has proven activity against breast cancer and is delivered in an easy-to-administer oral formulation. Orzel, which combines UFT with the oral biomodulator, calcium folinate, may provide even greater antitumor efficacy against breast cancer. Here, we describe the preliminary results of this phase II trial investigating the feasibility of 250 mg/...

Journal: :Oncology 1999
P M Hoff R Pazdur

Oxaliplatin is a unique platinum compound with single-agent activity in both chemotherapy-naïve colorectal cancer patients and patients who progressed on 5-fluorouracil (5-FU). The combination of oxaliplatin and 5-FU has demonstrated preclinical synergy, and recent clinical trials have demonstrated enhanced activity for the combination in the clinical setting as well. UFT (uracil plus tegafur i...

Journal: :Oncology 1999
P M Hoff Y Lassere R Pazdur N Janjan C Crane J Skibber

Protracted infusions of 5-fluorouracil (5-FU) combined with pelvic radiotherapy have been associated with improved survival and decreased local and distant metastases in the adjuvant therapy of rectal cancer. However, this method of 5-FU infusion requires the inconvenience and expense of central venous line placement and care, infusion pumps, and treatment of catheter-related complications. We ...

Journal: :Oncology 1999
F Robert D Raben S Spencer

A phase I, single-center, open-label, dose-escalation study (University of Alabama [UAB] 9614) has been undertaken to evaluate the feasibility and safety of uracil and tegafur (in a molar ratio of 4:1 [UFT]) plus oral calcium folinate (Orzel) plus radiotherapy in patients with pancreatic cancer. A total of 11 patients with a median age of 59 years have been treated for 35 days with 150 mg/m2/da...

L Ataei M Shahidi Dadras

Background: Mycosis fungoides (MF) is a cutaneous T cell lymphoma. There are only palliative treatments in advanced stages with no cure. Most chemotherapy regimens have temporary effects with various side effects. Objective: The objective of this study was to assess the efficacy of a new chemotherapy regimens in advanced stages of MF. This regimens takes advantage of synergistic effect of metho...

Journal: :International Journal of Cancer 2021

Perioperative chemotherapy with 5-fluorouracil, leucovorin, oxaliplatin and docetaxel (FLOT) is a mainstay in the treatment of esophagogastric adenocarcinomas (EGA). Trastuzumab improved survival when added to patients HER-2-positive metastatic EGA. We investigated combination trastuzumab FLOT as perioperative locally advanced A multicenter phase II study evaluated efficacy toxicity (24-hours 5...

Journal: :International Journal of Cancer 2021

Perioperative chemotherapy with 5-fluorouracil, leucovorin, oxaliplatin and docetaxel (FLOT) is a mainstay in the treatment of esophagogastric adenocarcinomas (EGA). Trastuzumab improved survival when added to patients HER-2-positive metastatic EGA. We investigated combination trastuzumab FLOT as perioperative locally advanced A multicenter phase II study evaluated efficacy toxicity (24-hours 5...

نمودار تعداد نتایج جستجو در هر سال

با کلیک روی نمودار نتایج را به سال انتشار فیلتر کنید